PRME EPS Estimates
Prime Medicine, Inc.
$3.99
+$0.41(+11.45%)
62
Overall
55
Value
91
Tech
42
Quality
Market Cap
$649.33M
Volume
8.06M
52W Range
$2.67 - $6.94
Target Price
$7.02
PRME EPS estimates: the consensus estimate for Prime Medicine, Inc.'s current fiscal year is -$0.97 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
PRME EPS Estimates
- EPS estimate, current quarter
- $-0.23
- EPS estimate, next quarter
- $-0.24
- EPS estimate, current year
- $-0.97
- EPS estimate, next year
- $-0.87
- EPS growth, 3-year
- +31.44%
| Fiscal year | EPS |
|---|---|
| 2025 | $-1.35 |
| 2024 | $-1.65 |
| 2023 | $-2.18 |
| 2022 | $-4.19 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PRME | $3.99 | +11.5% | 8.06M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |